Find clinical trials for Non-Hodgkin Lymphoma in St Louis, MO
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Non-Hodgkin Lymphoma trials near St Louis, MO, USA:
The purpose of this study is to evaluate the safety, tolerability, and preliminary efficacy of CC-99282 alone and in combination with anti-lymphoma...
Phase 1, Phase 2
Saint Louis, Missouri, United States and 88 other locations
and young adult participants with recurrent or refractory classical Hodgkin lymphoma and non-Hodgkin lymphoma...
Phase 1, Phase 2
Saint Louis, Missouri, United States and 73 other locations
administered orally in subjects with Relapsed/Refractory (r/r) Non-Hodgkin's Lymphoma (NHL) or Multiple Myeloma (MM) admin...
Phase 1, Phase 2
Saint Louis, Missouri, United States and 12 other locations
in participants with relapsed or refractory (R/R) CD30-expressing lymphomas.GEN3017 will be administered via subcutaneous injections.All par...
Phase 1, Phase 2
Saint Louis, Missouri, United States and 4 other locations
in participants with relapsed or refractory (R/R) solid tumors or non-Hodgkin lymphoma (NHL).Part 2: Cohort Expansion. The...
Phase 1, Phase 2
Saint Louis, Missouri, United States and 25 other locations
This is a First-in-Human Phase I trial of ATG-101 in Patients with Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin L....
Phase 1
Saint Louis, Missouri, United States and 7 other locations
gemcitabine, and oxaliplatin (R-GemOx).To evaluate the efficacy of magrolimab in combination with rituximab in participants with indolent lymphoma...
Phase 1, Phase 2
Saint Louis, Missouri, United States and 19 other locations
participants with relapsed or refractory (R/R) diffuse-large B-cell lymphoma (DLBCL), high-grade B-cell lymphoma, transformed folli...
Phase 3
Chesterfield, Missouri, United States and 72 other locations
and efficacy of RO7227166 in participants with relapsed/refractory Non-Hodgkin's Lymphoma (r/r NHL). RO7227166 will be adm...
Phase 1
Saint Louis, Missouri, United States and 16 other locations
This is a Phase I/II, multicenter, open-label, dose-escalation study designed to evaluate the efficacy, safety, tolerability and pharmacokinetics (PK...
Phase 1, Phase 2
Saint Louis, Missouri, United States and 40 other locations
Clinical trials
Research sites
Resources
Legal